Polymorbidity factor in the development of contrastinduced nephropathy in patients with acute myocardial infarction who underwent coronary angiography and percutaneous coronary intervention
https://doi.org/10.29001/2073-8552-2020-35-1-93-99
Abstract
Aim. To estimate the importance of polymorbidity factor in the development of contrast-induced nephropathy in patients with acute myocardial infarction who underwent computed tomography (CT) coronarography and percutaneous coronary intervention (PCI).
Material and Methods. We carried out the retrospective analysis of clinical cases of patients with acute myocardial infarction who underwent CT coronarography and PCI in N. S. Karpovich Emergency Hospital of Krasnoyarsk city in 2015. The sample consisted of 33 patients with a clinical verified diagnosis of contrast-induced nephropathy. We used the “R” and “G*Power” software for the statistical analysis of our data. Nonparametric methods of data analyses, such as analysis of variance of repeated measures and Mann-Whitney U-test were used. We also used the two-factor analysis of variance after logarithmic
data transformation. Data are presented as median and 25% and 75% quartiles.
Results. Among 33 sampled patients with diagnosed contrast-induced nephropathy, 15 patients were females and 13 patients were males. The mean age was 70.9 ± 11.5 years. We divided this sample into polymorbidity and non-polymorbidity groups. The mean creatinine level in polymorbidity patients was 127 μmol/L (95; 179). Non-polymorbidity patients had a creatinine level of 130 μmol/L (91; 179). We did not detect any significant impact of polymorbidity factor on the temporal changes in the creatinine level (p > 0.05) in patients with contrast-induced nephropathy. Paired comparison based on both logarithmic transformation data using T-test and non-transformed values using Mann – Whitney U test did not show any significant differences between the creatinine levels in polymorbidity and non-polymorbidity patients. The absence of a strong correlation between creatinine levels and polymorbidity at chosen time intervals in the presence of significantly increasing creatinine values may be explained by the influence of other factors. In our case, we attribute an impact of contrast medium on kidney filtration. Their high variability explains the asymmetric distribution of creatinine values both in the entire sample and in the subgroups. The polymorbidity factor should not require special attention in regard to patients with acute myocardial infarction who need emergency CT coronarography and life-saving PCI.
Conclusion. The polymorbidity factor did not significantly affect the development of contrast-induced nephropathy in patients with acute myocardial infarction undergoing CT coronarography and PCI.
Material and Methods. We carried out the retrospective analysis of clinical cases of patients with acute myocardial infarction who underwent CT coronarography and PCI in N. S. Karpovich Emergency Hospital of Krasnoyarsk city in 2015. The sample consisted of 33 patients with a clinical verified diagnosis of contrast-induced nephropathy. We used the “R” and “G*Power” software for the statistical analysis of our data. Nonparametric methods of data analyses, such as analysis of variance of repeated measures and Mann-Whitney U-test were used. We also used the two-factor analysis of variance after logarithmic
data transformation. Data are presented as median and 25% and 75% quartiles.
Results. Among 33 sampled patients with diagnosed contrast-induced nephropathy, 15 patients were females and 13 patients were males. The mean age was 70.9 ± 11.5 years. We divided this sample into polymorbidity and non-polymorbidity groups. The mean creatinine level in polymorbidity patients was 127 μmol/L (95; 179). Non-polymorbidity patients had a creatinine level of 130 μmol/L (91; 179). We did not detect any significant impact of polymorbidity factor on the temporal changes in the creatinine level (p > 0.05) in patients with contrast-induced nephropathy. Paired comparison based on both logarithmic transformation data using T-test and non-transformed values using Mann – Whitney U test did not show any significant differences between the creatinine levels in polymorbidity and non-polymorbidity patients. The absence of a strong correlation between creatinine levels and polymorbidity at chosen time intervals in the presence of significantly increasing creatinine values may be explained by the influence of other factors. In our case, we attribute an impact of contrast medium on kidney filtration. Their high variability explains the asymmetric distribution of creatinine values both in the entire sample and in the subgroups. The polymorbidity factor should not require special attention in regard to patients with acute myocardial infarction who need emergency CT coronarography and life-saving PCI.
Conclusion. The polymorbidity factor did not significantly affect the development of contrast-induced nephropathy in patients with acute myocardial infarction undergoing CT coronarography and PCI.
About the Authors
A. A. Ursta
Krasnoyarsk State Medical University named after Professor V. F. Voino-Yasenetsky;
Military Hospital No. 425, Branch No. 2
Russian Federation
Russian Federation
Assistant Professor, Department of Propaedeutics of Internal diseases and Therapy; Intensivist, Anesthesiology and Reanimatology Department
1, Partizan Zheleznyak str., Krasnoyarsk, 660022, Russian Federation
2, Gorky str., Krasnoyarsk, 660017, Russian Federation
A. R. Kotikov
Krasnoyarsk Territorial Bureau of Pathology
Russian Federation
Russian Federation
Cand. Sci. (Med.), Pathologist
1D, Partizan Zheleznyak str., Krasnoyarsk, 660022, Russian Federation
O. V. Ursta
Private Healthcare Facility “Teaching hospital” RZD-Medicine” of Krasnoyarsk city”
Russian Federation
Russian Federation
Cand. Sci. (Med.), Surgeon
47, Lomonosov str., Krasnoyarsk, 660058, Russian Federation
E. I. Kharkov
Krasnoyarsk State Medical University named after Professor V. F. Voino-Yasenetsky
Russian Federation
Russian Federation
Dr. Sci. (Med.), Professor, Head of the Department of Propaedeutics of Internal diseases and Therapy,
1, Partizan Zheleznyak str., Krasnoyarsk, 660022, Russian Federation
M. M. Petrova
Krasnoyarsk State Medical University named after Professor V. F. Voino-Yasenetsky
Russian Federation
Russian Federation
Dr. Sci. (Med.), Professor, Head of the Department of Policlinic Therapy and Family Medicine with Postgraduate Education Course
1, Partizan Zheleznyak str., Krasnoyarsk, 660022, Russian Federation
References
1. 1 ESUR Guidelines on Contrast Agents. European Society of Urogenital Radiology. URL: http://www.esur.org/fileadmin/content/2019/ESUR_Guidelines_10.0_Final_Version.pdf.
2. DuGoff E.H., Canudas-Romo V., Buttorff C., Leff B., Anderson G.F. et al. Multiple chronic conditions and life expectancy: a life table analysis. Med. Care. 2014;52(8):688–694. DOI: 10.1097/MLR.0000000000000166.
3. Oganov R.G., Denisov I.N., Simanenkov V.I., Bakulin I.G., Bakulina N.V., Boldueva S.A. et al. Comorbidities in practice. Clinical guidelines. Cardiovascular Therapy and Prevention. 2017;16(6):5–56 (In Russ.). DOI: 10.15829/1728-8800-2017-6-5-56.
4. Turenko O.I., Lebedeva A.Y., Gordeev I.G., Volov N.A. Сontrast-induced nephropathy in cardiology practice. Russian Journal of Cardiology. 2011;89(3):78–86 (In Russ.). DOI: 10.15829/1560-4071-2011-3-78-86.
5. Volgina G.V. Contrast-induced nephropathy: pathogenesis, risk factors, prevention strategies. Nephrology and Dialysis. 2006;8(2):176–183 (In Russ.).
6. Kalaeva V.N., Karetnikova V.N., Osokina A.V., Gruzdeva O.V., Kashtalap V.V., Evseeva M.V. et al. Risk factors of contrast-induced nephropathy in patients with myocardial infarction. Clinical Мedicine. 2014;9:39–45 (In Russ.).
7. Tepel M., Aspelin P., Lameire N. Contemporary reviews in cardiovascular medicine contrast-induced nephropathy: A clinical and evidence-based approach. Circulation. 2006;113:1799–1806. DOI: 10.1161/CIRCULATIONAHA.105.595090.
8. Nemik D.B., Matyushin G.V., Protopopov A.V., Shesternya P.A., Golovenkin C.E., Shulmin A.V. Effectiveness of early pre-hospital thrombolytic therapy with three percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction (current state of the problem). Siberian Medical Review. 2015;3:15–24 (In Russ.).
9. Vitko N.K., Ter-Akopyan A.V., Pankov A.S., Tagaev N.B. The use of contrast media in interventional cardiology and angiology: history, complications and its prevention. Russian Electronic Journal of Radiology. 2012;2(1):29–34 (In Russ.). URL: www.rejr.ru.
10. Domoradskaya A.I. Contrast induced nephropathy: risk factors. Russian Electronic Journal of Radiology. 2011;1(4):27–32 (In Russ.). URL: www.rejr.ru.
11. Dundua D., Kartashov D., Babunashvili A., Artamonova J., Kavteladze Z. Is nephropathy inevitable in response to contrast media injection? Medical Visualization. 2010;6:25–31 (In Russ.).
12. Vatutin N.T., Zinkovich M.I., Shevelek A.N. Prevalence of renal function lesion in patients with acute coronary syndrome. The Russian Archives of Internal Medicine. 2015;23(3):30–32 (In Russ.). DOI: 10.20514/2226-6704-2015-0-3-30-32.
13. Morcos S.K., Thomsen H.S., Webb J.A. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur. Radiol. 1999;9(8):1602–1613. DOI: 10.1007/s003300050894.
14. Makarycheva O.V., Hmara T.N., Nazarov A.V., Yakusheva N.V., Skrypnik D.V., Vasilieva E.Yu. et al. Urgent transcutaneous intervention and hospital prognosis in patients with ST-elevation acute myocardial infarction and compromised renal function. International Journal of Interventional Cardioangiology. 2011;24:84 (In Russ.).
15. Faul F., Erdfelder E., Buchner A., Lang A. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behavior Research Methods. 2009;41(4):1149–1160. DOI: 10.3758/brm.41.4.1149.
16. Vershinina E.O., Repin A.N. Contrast-induced acute kidney injury in planned endovascular interventions on the coronary arteries. Clinical Medicine. 2017;95(12):1086–1093 (In Russ.). DOI: 10.18821/0023-2149-2017-95-12-1086-1093.
17. Ariev A.I., Chesnokov A.A., Dzakhova S.D., Ovsiannikova N.A., Arieva G.T. Multimorbidity as one of risk predictors for contrast induced nephropathy in geriatric practice. Nephrology (Saint-Petersburg). 2017;21(1):34–38 (In Russ.). DOI: 10.24884/1561-6274-2017-21-1-34-38.
Review
For citations:
Ursta A.A., Kotikov A.R., Ursta O.V., Kharkov E.I., Petrova M.M. Polymorbidity factor in the development of contrastinduced nephropathy in patients with acute myocardial infarction who underwent coronary angiography and percutaneous coronary intervention. Siberian Journal of Clinical and Experimental Medicine. 2020;35(1):93-99. (In Russ.) https://doi.org/10.29001/2073-8552-2020-35-1-93-99
Views:
457
.png)
Email this article 